Everolimus after surgery may benefit patients with very-high-risk clear cell renal cell carcinoma

A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup of patients with clear-cell renal cell carcinoma (RCC) who were at very-high risk of recurrence, those who were treated with everolimus after surgery had a statistically significant improvement in recurrence-free survival compared to patients getting placebo after surgery.

Related Keywords

Oregon , United States , Spain , San Antonio , Texas , Madrid , Maxwell Meng , Igor Puzanov , Primon Lara Jr , Ajjais Alva , Josephi Clark , Neeraj Agarwal , Tonik Choueiri , Danielle Ellis , Naomib Haas , Ulkan Vaishampayan , Catherinem Tangen , Elisabethi Heath , Brianm Shuch , Christopherw Ryan , Sumantak Pal , Ianm Thompson , Robert Uzzo , Markn Stein , Wayne State University Karmanos Cancer Institute , Science University Knight Cancer Institute , Drug Administration , Oregon Health Science University Knight Cancer Institute , Temple Health , National Institutes Of Health , University Of California San Francisco , European Society Of Medical Oncology , University Of Utah , University Of Michigan Rogel Comprehensive Cancer Center , University Of California Davis School Medicine , National Clinical Trials Network , Oregon Health , Uc Davis Comprehensive Cancer Center , Cancer Research Network , Huntsman Cancer Institute , Loyola University Chicago Medical Center , Fox Chase Cancer Center , Data Management Center , School Of Medicine , Columbia University Herbert Irving Cancer Center , Dana Farber Cancer Institute , Abramson Cancer Center , National Cancer Institute , City Of Hope Comprehensive Cancer Center , Novartis Pharmaceuticals Corporation , University Of Pennsylvania , Roswell Park Comprehensive Cancer Center , European Society , Medical Oncology , California Davis School , Comprehensive Cancer Center , Research Network , National Institutes , Clinical Trials Network , Novartis Pharmaceuticals , Wayne State , Karmanos Cancer Institute , Herbert Irving Cancer Center , California San Francisco , Michigan Rogel Comprehensive Cancer Center , Hope Comprehensive Cancer Center , Melissa Plets , Science University Knight Cancer , Scarcinoma , Fell , Everolimus , Renal Cell Carcinoma , Adjuvant Therapy , Dancer , Distology , Medicine , Fact , Ncology , Placebo , Research , Surgery ,